SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 222 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $9,000 | -10.0% | 960 | 0.0% | 0.00% | – |
| Q2 2019 | $10,000 | -93.2% | 960 | -92.5% | 0.00% | -100.0% |
| Q4 2018 | $148,000 | -52.9% | 12,880 | -30.5% | 0.01% | -40.0% |
| Q3 2018 | $314,000 | +129.2% | 18,528 | +92.4% | 0.01% | +100.0% |
| Q2 2018 | $137,000 | +197.8% | 9,632 | +301.3% | 0.01% | +150.0% |
| Q1 2018 | $46,000 | – | 2,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 968,505 | $12,135,000 | 1.23% |
| Golden State Equity Partners | 126,608 | $1,586,000 | 0.90% |
| McGuire Investment Group, LLC | 272,801 | $3,418,000 | 0.72% |
| Lombard Odier Asset Management (Switzerland) SA | 848,429 | $10,631,000 | 0.70% |
| Rhenman & Partners Asset Management AB | 765,000 | $9,585,000 | 0.67% |
| EMC Capital Management | 72,061 | $903,000 | 0.64% |
| WASATCH ADVISORS LP | 10,328,423 | $129,415,000 | 0.58% |
| Ceeto Capital Group, LLC | 74,000 | $927,000 | 0.45% |
| Fort Sheridan Advisors LLC | 75,945 | $952,000 | 0.38% |
| Vanguard Capital Wealth Advisors | 34,580 | $388,679,000 | 0.33% |